Also trades as: 4506.T (JPX) · $vol 41M · DNPUF (OTC) · $vol 0M

$10.32

-0.12 (-1.20%)

Weekly Expected Move ±7.5%

$9 $10 $10 $11 $12

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 69 · $4.6B mcap · 238M float · 0.0004% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$480.6B +20.5% ▲

5Y CAGR: -1.4%

Gross Profit

$272.4B +11.0% ▲

5Y CAGR: -6.4%

Operating Income

$53.4B +85.3% ▲

5Y CAGR: -5.6%

Net Income

$113.3B +379.4% ▲

5Y CAGR: +15.0%

EPS (Diluted)

$286.01 +380.8% ▲

5Y CAGR: +15.1%

EBITDA

$75.4B +33.1% ▲

5Y CAGR: -6.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$560.0B	$555.5B	$314.6B	$398.8B	$480.6B
YoY Growth	+8.5%	-0.8%	-43.4%	+26.8%	+20.5%
Cost of Revenue	$157.1B	$178.9B	$126.6B	$153.4B	$208.2B
Gross Profit	$402.9B	$376.6B	$188.0B	$245.4B	$272.4B
Gross Margin	71.9%	67.8%	59.8%	61.5%	56.7%
R&D Expenses	$94.9B	$131.9B	$112.6B	$49.9B	$46.6B
SG&A Expenses	$217.3B	$339.2B	$429.5B	$180.6B	$172.4B
Operating Expenses	$342.7B	$453.6B	$542.2B	$216.6B	$219.0B
Operating Income	$60.2B	-$77.0B	-$354.2B	$28.8B	$53.4B
Operating Margin	10.8%	-13.9%	-112.6%	7.2%	11.1%
Interest Expense	$3.0B	$3.2B	$4.3B	$13.5B	$10.8B
Income Before Tax	$83.0B	-$47.9B	-$323.1B	$17.6B	$106.4B
Tax Expense	$42.4B	$48.8B	-$8.2B	-$6.0B	-$6.9B
Net Income	$56.4B	-$74.5B	-$315.0B	$23.6B	$113.3B
Net Margin	10.1%	-13.4%	-100.1%	5.9%	23.6%
EPS (Diluted)	$141.99	$-187.55	$-792.79	$59.49	$286.01
EBITDA	$124.4B	-$3.5B	-$281.1B	$56.7B	$75.4B
Shares Outstanding	397M	397M	397M	397M	397M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$90.7B	$90.1B	$112.4B	$105.6B	$108.0B	$121.2B	$122.8B	$107.5B
Cost of Revenue	$34.9B	$37.4B	$41.4B	$39.7B	$44.1B	$46.4B	$56.4B	$52.2B
Gross Profit	$55.7B	$52.7B	$71.0B	$66.0B	$63.9B	$74.8B	$66.4B	$55.3B
Gross Margin	61.5%	58.5%	63.1%	62.5%	59.2%	61.7%	54.0%	51.4%
R&D Expenses	$13.1B	$13.1B	$10.5B	$13.1B	$8.2B	$9.5B	$10.5B	$16.4B
SG&A Expenses	$45.4B	$44.6B	$41.0B	$49.6B	$35.7B	$41.6B	$43.7B	$43.9B
Operating Expenses	$58.8B	$57.8B	$49.6B	$50.4B	$43.5B	$51.1B	$54.2B	$60.3B
Operating Income	-$3.1B	-$5.1B	$21.4B	$15.6B	$20.4B	$23.7B	$12.1B	-$5.0B
Operating Margin	-3.4%	-5.7%	19.0%	14.7%	18.9%	19.5%	9.9%	-4.6%
Interest Expense	$2.0B	$23.4B	$0	$22.0B	$8.5B	$0	$5.2B	$468M
Income Before Tax	$17.2B	-$49.6B	$56.4B	-$6.4B	$11.9B	$82.3B	$8.9B	-$1.2B
Tax Expense	$1.3B	-$1.4B	$3.0B	-$8.8B	$726M	-$6.9B	-$81M	-$390M
Net Income	$15.9B	-$48.2B	$53.4B	$2.4B	$11.2B	$89.2B	$9.0B	-$827M
Net Margin	17.6%	-53.5%	47.5%	2.3%	10.4%	73.6%	7.3%	-0.8%
EPS (Diluted)	$40.11	$-121.24	$134.53	$6.08	$28.21	$225.00	$22.59	$-2.08
EBITDA	$26.1B	-$19.4B	$27.5B	$5.6B	$26.2B	$87.7B	$19.5B	$91M
Shares Outstanding	397M	397M	397M	397M	397M	397M	397M	398M

SMDPY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet